From Enemy Territory? NPC Nabs Ex-ICER VP
Executive Summary
Jonathan Campbell is the National Pharmaceutical Council's new chief science officer.
You may also be interested in...
IRA Updates: Lawsuit Filers Push For Fast Decisions, ICER Plans Cost Analyses
Merck & Co. requested a swift summary judgment in the Medicare drug price negotiation case it filed in Washington DC, while the US Chamber of Commerce filed for a preliminary injunction.
Intarcia’s Implantable GLP-1 Gets Unanimous No Vote But Lots Of New Trial Design Advice
US FDA advisory panel feels there could be a place for Intarcia’s exenatide drug-device combo – if the company is willing to put in the work.
As New Tech Emerges For Early Research, FDA Chief Scientist Says Diversity Must Start In Preclinical Development
In a Pink Sheet interview Chief Scientist Bumpus discusses need to move diversity conversation up further in the pipeline. Better ‘organs on a chip’ should help.